Iconic Labs PLC
LSE:ICON
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
EV/FCFF
Enterprise Value to Free Cash Flow to Firm (EV/FCFF) ratio compares a company`s total enterprise value to the free cash flow available to all investors, both debt and equity holders. It shows how much investors are paying for each dollar of cash flow the business generates before interest payments.
Enterprise Value to Free Cash Flow to Firm (EV/FCFF) ratio compares a company`s total enterprise value to the free cash flow available to all investors, both debt and equity holders. It shows how much investors are paying for each dollar of cash flow the business generates before interest payments.
Valuation Scenarios
If EV/FCFF returns to its Industry Average (0), the stock would be worth GBX-0.01 (100% downside from current price).
| Scenario | EV/FCFF Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | -10.1 | GBX1.5 |
0%
|
| Industry Average | 0 | GBX-0.01 |
-100%
|
| Country Average | 0 | GBX-0.01 |
-100%
|
Forward EV/FCFF
Today’s price vs future free cash flow to firm
Peer Comparison
| Market Cap | EV/FCFF | P/E | ||||
|---|---|---|---|---|---|---|
| UK |
|
Iconic Labs PLC
LSE:ICON
|
208.3k GBP | -10.1 | -0.3 | |
| US |
|
CVS Health Corp
NYSE:CVS
|
105.9B USD | 20 | 59.9 | |
| US |
C
|
Cigna Group
XMUN:CGN
|
72.9B EUR | 12.6 | 14.1 | |
| US |
|
Cigna Corp
NYSE:CI
|
76.6B USD | 0 | 12.9 | |
| DE |
|
Fresenius SE & Co KGaA
XETRA:FRE
|
23.2B EUR | 29.8 | 18.4 | |
| DE |
|
Fresenius Medical Care AG
XMUN:FME
|
22.4B EUR | 16.6 | 22.8 | |
| US |
|
Laboratory Corporation of America Holdings
NYSE:LH
|
21.1B USD | 21.2 | 24.1 | |
| US |
|
Quest Diagnostics Inc
NYSE:DGX
|
21.6B USD | 19.8 | 21.1 | |
| DE |
F
|
Fresenius Medical Care AG & Co KGaA
XETRA:FME
|
10.8B EUR | 9.9 | 11 | |
| US |
|
Guardant Health Inc
NASDAQ:GH
|
11.4B USD | -51 | -27.3 | |
| US |
|
DaVita Inc
NYSE:DVA
|
10.6B USD | 15.1 | 14.2 |
Market Distribution
| Min | 0 |
| 30th Percentile | 0 |
| Median | 0 |
| 70th Percentile | 0.1 |
| Max | 1 344.9 |
Other Multiples
Iconic Labs PLC
Glance View
Iconic Labs Plc is a media and technology business. The firm is focused on providing online marketing, content and technology driven products. The firm's principal activity within this sector is in digital and social media publishing. The firm owns certain publishers, such as GSN, and manages other publishers, such as The London Economic, JOE and Her and Lovin' Media through management services contracts (MSCs). Its subsidiaries include WideCells International Limited, WideCells Portugal SA, Iconic Labs UK Limited, Iconic Labs IP Limited and Nuuco Media Limited, among others.
